Clinical Trials Sponsored by PBM Products

Total 1819 results

PBM Nutritionals

Completed

Addition to Infant Formula of 2-fucosyllactose (2-FL) (2-FL)

Growth of Infants

United States, Honduras
PBM Healing International Limited

Recruiting

Impact of Photobiomodulation on Pain During Orthodontic Treatment.

Malocclusion | Orthodontic Treatment

Canada
PBM Healing International Limited

Completed

Impact of Photobiomodulation on Pain Associated With Orthodontic Treatment

Pain | Orthodontic

Japan
Stockholm University
PBM; Mimerse

Completed

Virtual Reality Exposure Therapy for Public Speaking Anxiety (VRETA)

Social Anxiety | Public Speaking | Social Anxiety Disorder, Performance Only

Sweden
Uppsala University
PBM Sweden AB

Active, not recruiting

A Biopsychosocial Treatment for Exhaustion Due to Persistent Non-traumatic Stress

Exhaustion Disorder | Clinical Burnout

Sweden
Uppsala University
PBM Sweden AB

Completed

Open Clinical Trial of CBT-based Multiprofessional Rehabilitation for Exhaustion Disorder

Burnout, Professional | Burnout Syndrome | Adjustment Disorders | Exhaustion; Syndrome

Sweden
Needed PBC

Recruiting

Prenatal Nutrient Status Study

Pregnancy Related | Nutrient Deficiency

United States
pfm S.R.L.

Completed

Safety and Effectiveness of the Device "Nit-Occlud® PDA-R"

Congenital Heart Disease

Bolivia
Pfm Medical Mepro Gmbh
pfm medical ag

Completed

National, Multicenter PMS Study "Patient Reported Outcome" in Breast Reconstruction Following Mastectomy With TiLOOP Bra (PRO-BRA)

Breast Reconstruction After Mastectomy

Germany
ABM Therapeutics Corporation

Recruiting

Safety and Effectiveness of ABM-168 in Adults With Advanced Solid Tumors.

Advanced Solid Tumor | RAS Mutation | NF1 Mutation | RAF Mutation

United States
pfm medical gmbh

Completed

Post-market Clinical Follow-up of Pfmmedical Ports

Patient Satisfaction | Vascular Access Port

Germany
ABM Therapeutics Corporation

Active, not recruiting

Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors

Advanced Solid Tumor | BRAF V600 Mutation

United States
PRM Pharma, LLC

Withdrawn

Effect of PRM-125 on Ambulatory Blood Pressure

Hypertension

United States
Lung Biotechnology PBC

Completed

A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients

Pulmonary Arterial Hypertension

United States, Ireland, Belgium
Lung Biotechnology PBC

Completed

An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients

Pulmonary Arterial Hypertension

United States, Belgium, Ireland
Lung Biotechnology PBC

Withdrawn

A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor

Pulmonary Arterial Hypertension
POM Wonderful LLC

Completed

Pomegranate Extract Biomarker Study in Osteopenic Women

Osteopenic Women

United States
Ross Products

Completed

Effect of Different Doses of Salacinol Extract on Glycemic and Insulinemic Response in Patients With Type 2 Diabetes

Diabetes Mellitus

United States
pfm medical gmbh

Recruiting

Post-market Clinical Follow-up of the SRS Implant

Pelvic Organ Prolapse

Germany
pfm medical ag

Completed

Post Market Clinical Follow Up to "Patient Reported Outcome" Using a Titanised Polypropylene Mesh (TiLOOP® Bra Pocket) (PRO-Pocket)

Breast Cancer | Breast Diseases | Breast Neoplasm | Breast Reconstruction After Mastectomy

Germany, Austria
Lung Biotechnology PBC

Completed

Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

United States, Belgium, Czechia, Germany, Ireland, Romania
Lung Biotechnology PBC

Terminated

A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension (BEAT OLE)

Pulmonary Arterial Hypertension

United States, Israel
Lung Biotechnology PBC

Completed

Beraprost-314d Added-on to Tyvaso® (BEAT) (BEAT)

Pulmonary Arterial Hypertension

United States, Israel
PBB Entrepreneur Ltd.

Completed

Efficacy and Tolerability of Topical Rossoseq™ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic)

Rosacea Subtype 1 (Erythematotelangiectatic)

Germany
POM Wonderful LLC

Completed

Safety and Efficacy of POMx Capsules in Men With Recurrent Prostate Cancer: An 18-Month Study

Recurrent Prostate Cancer

United States
GAP Innovations, PBC

Completed

A Biomarker Database to Investigate Blood-Based and Digital Biomarkers in Participants Screened for Alzheimer's Disease (Bio-Hermes)

Alzheimer Disease | Mild Cognitive Impairment | Alzheimer Disease, Early Onset | Memory Disorders | Memory Impairment | Memory Loss

United States
Lung Biotechnology PBC

Completed

Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients

Pulmonary Arterial Hypertension

United States, Belgium, Czechia, Germany, Ireland, Romania
PPM Services S.A.

Terminated

Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC (SEGMENT)

Ulcerative Colitis

United States, Hungary, Slovakia, Italy, Ukraine, Bulgaria, Poland, Latvia, Canada, France
Lung Biotechnology PBC

Terminated

Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis | Pulmonary Hypertension

United States
PFM Medical, Inc

Completed

NIT-OCCLUD PDA Phase II Sentinel Trial

Ductus Arteriosus, Patent

United States
Trek Therapeutics, PBC

Completed

A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection

Chronic Hepatitis C | Hepatitis C Genotype 1 | Hepatitis C (HCV) | Hepatitis C Viral Infection

United States, New Zealand
Trek Therapeutics, PBC

Completed

A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection

Chronic Hepatitis C | Hepatitis C (HCV) | Hepatitis C Genotype 4 | Hepatitis C Viral Infection

United States
POM Wonderful LLC

Completed

A Pilot Study to Evaluate the Effect of Pomegranate Juice on Semen Parameters in Healthy Male Volunteers

Male Infertility

United States
POM Wonderful LLC

Completed

Trial to Evaluate the Use of Pomegranate Concentrate (POMx) for the Prevention of Experimental Rhinovirus Infection

Common Cold

United States
Neopenda, PBC
Makerere University

Completed

Feasibility and Accuracy of a Wireless Vital Sign Monitor for Observation of Adult Patients in Uganda

Critical Illness

Uganda
Kind Lab PBC.
Citruslabs

Completed

Study to Evaluate the Efficacy of Bite's Natural Deodorant

Sweat | Underarm Odor

United States
MycoMedica Life Sciences PBC

Recruiting

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLS101 in Healthy Participants

Healthy Volunteers

Australia
AST Products, Inc.

Not yet recruiting

Safety and Efficacy of the Hydrophobic Intraocular Lens AsqelioTM Monofocal With Biaspheric Design

Cataract | Pseudophakia

Spain
Manitoba Starch Products

Completed

Effects of Resistant Potato Starch on the Gut Microbiota

Microbiota

Canada
Bio Products Laboratory

Completed

Registry Study of COAGADEX® Patients With Moderate or Severe Hereditary Factor X Deficiency Undergoing Major Surgery

Factor 10 Deficiency

United States
Bio Products Laboratory

Terminated

Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia A

Haemophilia A

Colombia, Germany, Poland
P1vital Products Limited

Completed

Predicting Response to Depression Treatment (PReDicT)

Depression

Spain, France, Germany, United Kingdom, Netherlands
Bio Products Laboratory

Terminated

Safety & Efficacy of BPL's High Purity FACTOR X in Treatment of Factor X Deficient Subjects Undergoing Surgery (Ten03)

Factor X Deficiency

United Kingdom, United States, Spain, Turkey
Bio Products Laboratory

Completed

An Open Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients

Haemophilia B

United Kingdom, Poland
Bio Products Laboratory

Completed

An Open-study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Subjects Undergoing Surgery

Haemophilia B

Poland, Romania, Russian Federation
Bio Products Laboratory

Completed

A Study of the Safety and Efficacy of Vigam® Liquid in Patients With Primary or Secondary Antibody Deficiency

Primary or Secondary Antibody Deficiency

United Kingdom
Bio Products Laboratory

Completed

A Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemophilia A.

Von Willebrand Disease

Poland, United Kingdom
Bio Products Laboratory

Completed

A Study to Investigate the Safety and Efficacy of Optivate® in Children Under 6 Years of Age With Haemophilia A.

Haemophilia A

Poland
Bio Products Laboratory

Completed

A Multi-centre Open Study to Assess the Safety and Efficacy of Subgam®

Primary Antibody Deficiency

United Kingdom
Bio Products Laboratory

Completed

Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases (GMX07)

Common Variable Immunodeficiency | Primary Immune Deficiency Disorders | Hyper-IgM Syndrome | X-linked Agammaglobulinaemia

United States, United Kingdom, Hungary

Clinical Trials Sponsored by PBM Products

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations